Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 4:11 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1441–1464 of 3,580 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: patch Clear all

Conditions: Contact Dermatitis
Interventions: T.R.U.E. TEST® Skin Patch Test: Dose Response Allergens; Biological
Lead sponsor: Allerderm; Industry
Eligibility: 18 Years and older
Enrollment: 235 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 4
States / cities: Little Rock, Arkansas • Shawnee Mission, Kansas • Louisville, Kentucky + 1 more

Conditions: Head and Neck Cancer
Interventions: Flexible Fiber-based CO2 Laser, Quality of Life forms, electrocautery resection and quality of life forms; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2021
U.S. locations: 4
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • New York, New York + 1 more

Conditions: Photophobia, Traumatic Brain Injury, Migraine
Interventions: Pupillography, Ocular Coherence Tomography (OCT), Wrist-watch sensor device, Videography, Electrophysiology; Device
Lead sponsor: Randy Kardon; Other
Eligibility: 18 Years to 80 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Epilepsy, Focal Cortical Dysplasia, Tuberous Sclerosis, Hemimegalencephaly, Polymicrogyria, Rasmussen Encephalitis, Sturge-Weber Syndrome, Gliosis, Stroke, Tumor, Brain
Interventions: Intra-operative brain tonometry; Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Vascular Disease, Peripheral
Interventions: Nanoparticle Paclitaxel; Drug
Lead sponsor: Celgene Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 7
States / cities: Sacramento, California • Gainsville, Florida • Davenport, Iowa + 4 more

Conditions: Colon Lesions
Interventions: Peptide application; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Atherosclerosis
Interventions: Eagle Eye Platinum digital IVUS catheter with optional SyncVision, Resolute Onyx Drug Eluting Stent, Onyx Frontier Drug Eluting Stent, Onyx TruStar Drug Eluting Stent, Onyx TruCor Drug Eluting Stent; Device
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 3,100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 40
States / cities: Tucson, Arizona • Little Rock, Arkansas • La Jolla, California + 36 more

Conditions: Defect of Articular Cartilage
Interventions: Hyalofast, Microfracture; Device · Procedure
Lead sponsor: Anika Therapeutics, Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2026
U.S. locations: 18
States / cities: Tempe, Arizona • Los Angeles, California • San Diego, California + 14 more

Conditions: Alzheimer Disease
Interventions: Rivastigmine 5 cm^2, Rivastigmine 10 cm^2, Rivastigmine 15 cm^2, Placebo to 15 cm^2 patch, Placebo to 10 cm^2 patch; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 50 Years to 85 Years
Enrollment: 1,584 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 65
States / cities: Birmingham, Alabama • Gilbert, Arizona • Phoenix, Arizona + 61 more

Conditions: Pancreatic Cysts, Pancreatic Mucinous-Cystic Neoplasm, Intraductal Papillary Mucinous Neoplasm, Solid Pseudopapillary Tumour of the Pancreas, Cystadenocarcinoma, Serous Cystadenoma
Interventions: Endoscopic ultrasound guided needle based confocal endomicroscopy; Procedure
Lead sponsor: University of Medicine and Pharmacy Craiova; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 5
States / cities: New Orleans, Louisiana • Boston, Massachusetts • New York, New York + 2 more

Conditions: Burn Wound
Interventions: Low-Irradiance Monochromatic Biostimulation (LIMB) Device, Standard of Care; Device · Other
Lead sponsor: Rogers Sciences Inc.; Industry
Eligibility: Up to 21 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Acute Pain, Ankle Sprain
Interventions: Diclofenac Sodium, Matching Placebo Patch; Drug
Lead sponsor: Cerimon Pharmaceuticals; Industry
Eligibility: 17 Years to 75 Years
Enrollment: 219 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Coronary Atherosclerosis
Interventions: Blinded IVUS assessment, Nonblinded IVUS; Device
Lead sponsor: Volcano Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 195 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Multiple Sclerosis
Interventions: Acetazolamide, Placebo; Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 55 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Food Allergy
Interventions: Viaskin Milk 150 mcg, Viaskin Milk 300 mcg, Viaskin Milk 500 mcg, Viaskin Placebo; Biological
Lead sponsor: DBV Technologies; Industry
Eligibility: 2 Years to 17 Years
Enrollment: 198 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 12
States / cities: Little Rock, Arkansas • San Diego, California • Stanford, California + 9 more

Conditions: Pancreatic Cyst
Interventions: EUS-guided RFA treatment; Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Bone Diseases
Interventions: Vitoss Alone, Vitoss with Bone Marrow Aspirate; Device
Lead sponsor: State University of New York - Upstate Medical University; Other
Eligibility: Not listed
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2011
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Smoking Cessation
Interventions: Exenatide, NRT, Counseling, Placebo; Drug · Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 75 Years
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Tobacco Use Disorder, HIV
Interventions: PSFW+, AHA, Nicotine polacrilex; Behavioral · Drug
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 512 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 2
States / cities: Baltimore, Maryland • The Bronx, New York

Conditions: Coronary Disease
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years and older
Enrollment: 340 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2007
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Peripheral Artery Disease
Interventions: Diamondback 360 Extended Length Orbital Atherectomy System; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 6
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Lafayette, Louisiana + 2 more

Conditions: Cervical Cancer, Tobacco Use, Smoking Cessation
Interventions: Self-Help Materials, Nicotine Patch, REDCap, Saliva Test, Telephone Counseling Sessions, Nicotine lozenge; Behavioral · Drug · Procedure
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 202 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 3
States / cities: Tampa, Florida • Oklahoma City, Oklahoma

Conditions: Colorectal Neoplasms, Digestive System Diseases, Colonic Diseases, Colorectal Cancer
Interventions: Not listed
Lead sponsor: Exact Sciences Corporation; Industry
Eligibility: 40 Years to 90 Years
Enrollment: 435 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 20
States / cities: Birmingham, Alabama • Huntsville, Alabama • Atlanta, Georgia + 14 more

Conditions: Metastasis to Vertebral Column
Interventions: Not listed
Lead sponsor: DFINE Inc.; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 8
States / cities: Escondido, California • Los Angeles, California • Kansas City, Kansas + 5 more

Search by objective public record fields.

Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy

A Single Center Randomized Controlled Trial Assessing Pain and Quality of Life Following Surgery

Objectively Diagnose and Monitor Treatment of Light Sensitivity

Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery

Prevention of Restenosis Following Revascularization

A Phase I In-Vivo Peptide Applied in the Right Colon

IMPact on Revascularization Outcomes of IVUS Guided Treatment of Complex Lesions and Economic Impact

HyaloFAST Trial for Repair of Articular Cartilage in the Knee

Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline

Needle-based Confocal Laser Endomicroscopy on Pancreatic Cystic Lesions

Safety Study of a Novel Wearable Phototherapy System for the Management of Acute Burn Wounds

Diclofenac Patch for Treatment of Acute Pain Due to Mild to Moderate Ankle Sprain

Bifurcation Lesion Analysis and STenting / BLAST

Augmenting Cerebral Blood Flow to Treat Established Multiple Sclerosis

Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy

Safety and Efficacy of EUS-RFA in the Treatment of Pancreatic Lesions: A Prospective Registry

Comparing Synthetic Bone Alone Versus Synthetic Bone With Bone Marrow in Bone Lesions

Exenatide Once Weekly for Smoking Cessation

RCT of an Internet Cessation Program Plus Online Social Network for HIV+ Smokers

Comparison of the Risk of Stroke With On- Versus Off-Pump Coronary Artery Bypass Grafting

Radial accEss for nAvigation to Your CHosen Lesion for Peripheral Vascular Intervention: REACH PVI

Smoking Cessation for Cervical Cancer Survivors

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

The STAR Prospective Clinical Series